VENROCK ASSOCIATES V LP

CIK 1391289 · last filed 2022-02-18

VENROCK ASSOCIATES V LP is a corporate insider who has filed 7 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for CSLT, was dated Feb 18, 2022. Across all open-market trades the lifetime net is −$77.0M, making them a net seller over the disclosed history. The firm reports its address in Palo Alto, CA. 38 SEC filings were submitted jointly with VENROCK PARTNERS V L P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

5

Total Filings

7

Lifetime Open-Market Net

-$76.98M

Filer Profile

Reported Address

3340 HILLVIEW AVENUE
PALO ALTO, CA 94304

Phone

(650) 475-3734

Related Filers

VENROCK PARTNERS V L P — 38 joint filings, latest 2022-02-18

Venrock Management V, LLC — 38 joint filings, latest 2022-02-18

Venrock Partners Management V, LLC — 38 joint filings, latest 2022-02-18

VEF Management V, LLC — 33 joint filings, latest 2022-02-18

BRYAN E ROBERTS — 4 joint filings, latest 2012-09-24

Venrock Associates VI, L.P. — 3 joint filings, latest 2022-02-18

Venrock Partners VI, L.P. — 3 joint filings, latest 2022-02-18

Anders D Hove — 1 joint filings, latest 2013-03-19

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CASTLIGHT HEALTH, INC. (CSLT) Delisted	10%+ Owner	0	$2.05	$0	$0	1	2022-02-18
Receptos, Inc. (RCPT) Delisted	10%+ Owner	1,832,761	—	—	-$33.08M	1	2013-11-25
Zeltiq Aesthetics Inc (ZLTQ) Delisted	10%+ Owner	5,458,233	—	—	-$42.16M	1	2013-11-18
Anacor Pharmaceuticals, Inc. (ANAC) Delisted	10%+ Owner	3,725,535	$10.19	$37.96M	-$1.75M	3	2012-09-24
CDE	10%+ Owner	0	$21.24	$0	$0	1	2012-08-06

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-02-18	CASTLIGHT HEALTH, INC. (CSLT) Delisted	Disp (D)	−52,552,640	$0	EDGAR
2013-11-25	Receptos, Inc. (RCPT) Delisted	Sell (S)	−1,500,000	-$33.08M	EDGAR
2013-11-18	Zeltiq Aesthetics Inc (ZLTQ) Delisted	Sell (S)	−3,450,000	-$42.16M	EDGAR
2012-09-24	Anacor Pharmaceuticals, Inc. (ANAC) Delisted	Sell (S)	−96,365	-$607.3K	EDGAR
2012-09-18	Anacor Pharmaceuticals, Inc. (ANAC) Delisted	Sell (S)	−175,000	-$1.14M	EDGAR
2012-08-06	CDE	Disp (D)	−36,976,464	$0	EDGAR
2012-07-05	Anacor Pharmaceuticals, Inc. (ANAC) Delisted	Other (J)	−4,102,750	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.